Akums Drugs and Pharmaceuticals Key Metrics
BSE: 544222 | NSE: AKUMS | ISIN: INE09XN01023 | Sector: Biotechnology & Drugs| Return on average equity - 5 year average | 6.00 |
| Net Income/employee - trailing 12 month | 3,98,923.30 |
| Revenue/employee - most recent fiscal year | 58,61,652.00 |
| Return on investment - most recent fiscal year | 6.80 |
| Return on average assets - most recent fiscal year | 5.36 |
| Receivables turnover - most recent fiscal year | 5.56 |
| Return on investment - trailing 12 month | 0.00 |
| Return on average assets - trailing 12 month | 0.00 |
| Inventory turnover - most recent fiscal year | 3.80 |
| Inventory turnover - trailing 12 month | 0.00 |
| Revenue/employee - trailing 12 month | 61,35,497.00 |
| Return on average assets - 5 year average | 2.52 |
| Net Income/employee - most recent fiscal year | 3,44,781.80 |
| Return on average equity - trailing 12 month | 0.00 |
| Receivables turnover - trailing 12 month | 0.00 |
| Asset turnover - most recent fiscal year | 0.91 |
| Asset turnover - trailing 12 month | 0.00 |
| Return on average equity - most recent fiscal year | 8.02 |
| Return on investment - 5 year average | 3.66 |
Akums Drugs and Pharmaceuticals Quick Links
Akums Drugs and Pharmaceuticals Dividend Akums Drugs and Pharmaceuticals Bonus Akums Drugs and Pharmaceuticals News Akums Drugs and Pharmaceuticals AGM Akums Drugs and Pharmaceuticals Rights Akums Drugs and Pharmaceuticals Splits Akums Drugs and Pharmaceuticals Board Meetings Akums Drugs and Pharmaceuticals Shareholdings Akums Drugs and Pharmaceuticals Profit Loss Akums Drugs and Pharmaceuticals Balance Sheet Akums Drugs and Pharmaceuticals Cashflow Akums Drugs and Pharmaceuticals Q1 Results Akums Drugs and Pharmaceuticals Q2 Results Akums Drugs and Pharmaceuticals Q3 Results Akums Drugs and Pharmaceuticals Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.